What Is HDL-P and Why Is It Important for Heart Health?

HDL-P, short for HDL particle number, is a count of how many individual high-density lipoprotein particles are circulating in your blood, and it appears to predict cardiovascular risk more reliably than the standard HDL cholesterol number on a typical lipid panel. Most people are familiar with HDL-C, the amount of cholesterol carried inside HDL particles, which is what shows up as “good cholesterol” on routine blood work. But two people with the same HDL-C level can have very different numbers of HDL particles, and that difference turns out to matter for the heart.

How HDL-P Differs From HDL Cholesterol

Think of HDL particles as individual trucks and HDL cholesterol as the cargo they carry. Some trucks are large and haul a lot of cholesterol per trip. Others are small and carry less. Your standard blood test only weighs the total cargo, so it cannot tell you how many trucks are on the road. HDL-P counts the trucks themselves. That distinction matters because much of what HDL does to protect arteries depends on having enough functional particles available, not simply on how much cholesterol those particles happen to be carrying.

A person could have a respectable HDL-C reading of, say, 55 mg/dL but have relatively few large, cholesterol-rich particles doing the work. Another person with the same HDL-C level might have many smaller particles. Their risk profiles can look quite different even though the standard lab result is identical. Research has consistently found that reduced concentrations of circulating HDL particles can be a better predictor of cardiovascular disease than HDL-C levels alone.¹

What HDL Particles Actually Do

The protective reputation of HDL rests largely on a process called reverse cholesterol transport: HDL particles scavenge excess cholesterol from artery walls and ferry it back to the liver for disposal. Each particle that docks with a cell and picks up cholesterol represents one trip in that cleanup cycle, so more particles generally means more cleanup capacity. Both HDL-P and a related measure called cholesterol efflux capacity are inversely associated with cardiovascular events, meaning people with higher values tend to have fewer heart attacks and strokes.²

Cholesterol removal is only part of the story, though. HDL particles also carry an enzyme called paraoxonase-1 (PON1) that breaks down harmful oxidized fats. When LDL cholesterol oxidizes inside artery walls, it triggers the kind of inflammatory damage that builds plaques. PON1 on HDL particles prevents that oxidation from escalating, protecting LDL particles, the cells lining blood vessels, and even the HDL particles themselves from oxidative damage.³ HDL particles also have broader anti-inflammatory properties, and when those properties are impaired, clinical outcomes worsen. A study of patients with acute heart failure found that impaired HDL antioxidant and anti-inflammatory function was linked to increased mortality.⁴

Proteomic research has added more complexity to this picture. HDL particles carry upwards of 70 different proteins, many of which have physiological roles well beyond lipid metabolism.⁵ This means HDL is not a single entity doing one job. It is a diverse family of particles with different protein cargoes, and simply measuring the cholesterol they carry misses almost everything about what they are doing.

The Evidence Linking HDL-P to Heart Disease Risk

A large study examining HDL particle concentration and coronary artery disease found that after adjusting for other lipid factors like apolipoprotein B and triglycerides, HDL-C’s association with heart disease risk disappeared entirely. HDL particle concentration, by contrast, stayed strongly protective, with people in the highest quartile of HDL-P having roughly half the odds of coronary artery disease compared to those in the lowest quartile.⁶ That finding is striking because it suggests that when you account for the metabolic environment more carefully, HDL-C on its own does not independently predict risk the way HDL-P does.

In people with type 1 diabetes, the relationship between HDL particle subspecies and coronary risk has been mapped in finer detail. Higher concentrations of extra-small HDL particles were associated with a dramatic reduction in coronary artery disease risk, while total HDL-P and medium-sized HDL particles also showed protective associations.⁷ The finding about extra-small particles is surprising because the traditional assumption was that bigger HDL meant better HDL. Reality appears more nuanced, and the field is still sorting out which particle sizes matter most in different populations.

When HDL-C and HDL-P Disagree

Doctors call it “discordance” when the cholesterol content of your lipoproteins and the particle count tell different stories. You could have normal or even high HDL-C but a low particle count, or the reverse. This discordance is especially common in people with metabolic syndrome or diabetes, and it can lead to a false sense of security if you are only looking at the standard cholesterol number.

Data from the Multi-Ethnic Study of Atherosclerosis (MESA) illustrate why this matters. In participants with diabetes, lower HDL-P independently predicted coronary heart disease even after adjusting for other risk factors, and the study concluded that examining lipoprotein particles and discordances has a potential role in assessing risk for people with metabolic syndrome and diabetes.⁸ If you have insulin resistance, prediabetes, or full-blown diabetes and your doctor only checks HDL-C, you could be missing a warning sign that HDL-P would reveal.

The High HDL-C Paradox

One of the more counterintuitive findings in cardiovascular research is that very high HDL-C levels may actually increase mortality. In the Copenhagen Heart Studies, women with HDL-C above about 135 mg/dL and men with HDL-C above about 97 mg/dL showed increased risk of dying from cardiovascular disease and from all causes.⁹ If HDL cholesterol were the whole story, more of it should always be better. The fact that it is not suggests something about the quality or function of those particles matters more than the raw cholesterol content.

HDL-P helps make sense of this paradox. People with extremely high HDL-C may have fewer but very large, cholesterol-engorged particles. Fewer particles means fewer trips to remove cholesterol from arteries, fewer antioxidant enzymes at work, and less anti-inflammatory coverage, regardless of how much cholesterol each particle holds. This is the clearest real-world illustration of why counting particles adds something that measuring cholesterol alone cannot.

HDL-P and Metabolic Syndrome

The Dallas Heart Study followed a multi-ethnic population and found that people in the lowest quartile of HDL-P had roughly twice the risk of developing metabolic syndrome compared to those in the highest quartile. What made the finding especially compelling was that adjusting for other metabolic risk factors, including visceral fat, triglyceride-to-HDL-C ratio, BMI, and insulin resistance, did not weaken the association.¹⁰ In other words, low HDL-P was not simply riding along with other markers of poor metabolic health. It carried independent predictive power.

Researchers have also found that having more metabolic syndrome criteria tends to shift the HDL particle distribution toward smaller particles and away from large ones.¹¹ While small HDL particles are not necessarily “bad” individually, this overall shift in particle composition tracked alongside greater inflammation and insulin resistance.

How HDL-P Is Measured

The primary clinical tool for measuring HDL-P is nuclear magnetic resonance (NMR) spectroscopy. NMR works by analyzing the signals that lipoproteins emit in a magnetic field, giving concentrations of total HDL particles as well as subclasses broken down by size: small, medium, and large.¹² The test is relatively fast and inexpensive compared to older research methods like ultracentrifugation, which made it feasible for large-scale clinical and translational studies.¹³

That said, the measurement is not without controversy. A recent critical review noted that discrepancies exist between NMR-derived HDL-P numbers and results from other methods like gel electrophoresis, ion mobility analysis, and size-exclusion chromatography. These methods can disagree about how many particles of each size are present and about the ratio of apolipoprotein A-I (the main structural protein of HDL) to HDL particles.¹⁴ The inconsistencies do not mean the test is useless, but they do mean that comparing HDL-P values between labs or between studies that used different platforms requires caution. The absolute number on your report matters less than where it falls relative to the reference range of the specific assay used.

Can You Change Your HDL-P?

Exercise and weight loss both appear to improve HDL particle profiles. In people with metabolic syndrome, combining weight loss with exercise shifted the HDL lipid composition and particle size toward healthier patterns, with the combined approach having a greater effect than weight loss alone.¹⁵ A separate study of severely obese women found that increasing the duration of physical activity was associated with favorable changes in lipoprotein particle concentrations, regardless of whether participants lost fat mass.¹⁶ That second finding is worth emphasizing: you do not necessarily have to lose weight to improve your lipoprotein particle profile if you can become more active.

Statins, the most widely prescribed cholesterol-lowering drugs, have a modest effect on HDL-P. In the large JUPITER trial, rosuvastatin at a standard dose increased HDL particle number by about 5% and HDL-C by about 8%, while also raising apolipoprotein A-I by about 4%.¹⁷ Interestingly, the same study found that rosuvastatin did not change cholesterol efflux capacity, meaning it added more particles without making each particle better at its cleanup job. A separate analysis of the same drug confirmed these modest HDL-P increases and added that average HDL particle size increased slightly as well.¹⁸ So statins help somewhat, but they are not a strong lever for HDL-P the way they are for LDL.

Genetic Evidence and What It Tells Us

Mendelian randomization studies, which use naturally occurring genetic variants to test whether a biomarker is causally linked to disease rather than just correlated with it, have muddied the HDL picture in an important way. A Mendelian randomization analysis found that genetically determined HDL cholesterol and apolipoprotein A-I levels were not associated with coronary artery disease.¹⁹ This does not mean HDL is irrelevant to heart disease, but it does suggest that simply having genetically high HDL-C does not protect you. It is consistent with the broader theme that HDL function and particle count matter more than the cholesterol cargo alone.

This genetic evidence also helps explain why drugs designed to dramatically raise HDL-C, such as the CETP inhibitors that were tested in large trials over the past two decades, largely failed to reduce cardiovascular events despite succeeding at their biochemical goal. Raising the cargo did not automatically mean raising functional particle activity. The lesson from genetics and from failed drug trials points in the same direction: HDL’s value lies in what its particles do, not in how much cholesterol they happen to carry.

HDL in Chronic Kidney Disease

People with chronic kidney disease (CKD) face an outsized cardiovascular risk, and their HDL particles are part of the reason. CKD not only reduces HDL cholesterol concentrations but also modifies the composition of HDL particles, and growing evidence suggests that in CKD and other chronic inflammatory disorders, HDL can lose its antiatherosclerotic properties and become dysfunctional.²⁰ In this setting, an HDL-C level that looks acceptable on paper may be deeply misleading because the particles behind that number are structurally altered and less capable of performing their protective roles. This is another population where HDL-P or functional assays could theoretically add clinical value beyond the standard panel.

Air Pollution and HDL Particles

An unexpected factor that appears to affect HDL-P is the air you breathe. Data from the Multi-Ethnic Study of Atherosclerosis (MESA) found that higher concentrations of fine particulate matter (PM2.5) were associated with lower HDL particle counts. A 5-microgram-per-cubic-meter increase in three-month average PM2.5 was linked to a measurable drop in HDL-P.²¹ The mechanism likely involves the systemic inflammation and oxidative stress that airborne pollutants trigger. This finding adds environmental exposure to the list of things that can erode HDL particle counts alongside the more familiar culprits of inactivity, poor diet, and metabolic disease.

Should You Ask Your Doctor for an HDL-P Test?

HDL-P is not part of the standard lipid panel that most doctors order during a routine checkup. It requires an NMR-based test, which is commercially available but typically ordered as an “advanced lipid panel” or “NMR LipoProfile.” Insurance coverage varies, and many clinicians still rely on the traditional HDL-C number because major clinical guidelines have not yet formally incorporated HDL-P into risk calculators.

The strongest case for ordering HDL-P is when there is reason to suspect discordance between cholesterol content and particle count. If you have metabolic syndrome, type 2 diabetes, insulin resistance, or a strong family history of heart disease despite what looks like a favorable standard lipid panel, knowing your particle count adds a layer of information that HDL-C alone cannot provide. The test is also worth considering if your HDL-C is very high but you have other cardiovascular risk factors, since the high-HDL-C paradox means that reassuringly high numbers are not always what they seem.

For someone with a clean metabolic profile, no family history, and standard risk factors well controlled, the incremental benefit of knowing HDL-P is likely small. The test adds the most when the conventional picture does not quite add up, and that is the situation where asking for it makes the most practical sense.